SI1501517T1 - Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention - Google Patents

Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention

Info

Publication number
SI1501517T1
SI1501517T1 SI200330899T SI200330899T SI1501517T1 SI 1501517 T1 SI1501517 T1 SI 1501517T1 SI 200330899 T SI200330899 T SI 200330899T SI 200330899 T SI200330899 T SI 200330899T SI 1501517 T1 SI1501517 T1 SI 1501517T1
Authority
SI
Slovenia
Prior art keywords
treatment
long
pharmaceutical combination
benign prostatic
prostatic hyperplasia
Prior art date
Application number
SI200330899T
Other languages
Slovenian (sl)
Inventor
Wolfgang Baiker
Ludwig Mehlburger
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002118392 external-priority patent/DE10218392A1/en
Priority claimed from DE2002118611 external-priority patent/DE10218611A1/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Priority claimed from EP03725053A external-priority patent/EP1501517B1/en
Publication of SI1501517T1 publication Critical patent/SI1501517T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
SI200330899T 2002-04-24 2003-04-17 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention SI1501517T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2002118392 DE10218392A1 (en) 2002-04-24 2002-04-24 Pharmaceutical combination of tamsulosin and finasteride useful for treating benign prostatic hyperplasia
DE2002118611 DE10218611A1 (en) 2002-04-25 2002-04-25 Pharmaceutical combination of tamsulosin and dutasteride useful for treating benign prostatic hyperplasia
EP03725053A EP1501517B1 (en) 2002-04-24 2003-04-17 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
PCT/EP2003/004034 WO2003090753A1 (en) 2002-04-24 2003-04-17 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention

Publications (1)

Publication Number Publication Date
SI1501517T1 true SI1501517T1 (en) 2007-10-31

Family

ID=37507468

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330899T SI1501517T1 (en) 2002-04-24 2003-04-17 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention

Country Status (1)

Country Link
SI (1) SI1501517T1 (en)

Similar Documents

Publication Publication Date Title
IL169685A0 (en) Treatment of benign prostatic hyperplasia using energolytic agents
EP1887976B8 (en) Devices for treating benign prostatic hyperplasia and other conditions
DE60023982D1 (en) System for the treatment of benign prostatic hyperplasia
MXPA02004106A (en) Local prevention or amelioration of pain from surgically closed wounds.
IL161110A0 (en) Prevention and treatment of restenosis by local admistration of drug
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
AU2495200A (en) Compositions and methods for the treatment of tumor
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
ZA200208228B (en) Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis
EP1743656A3 (en) Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
IL158206A0 (en) Compositions and methods for the prevention and treatment of human prostate cancer
HK1085373A1 (en) Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms
IL194463A0 (en) Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound
ZA991315B (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
EE200300057A (en) Ingredients for the prevention and treatment of cancer
SI1501517T1 (en) Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
GB0301016D0 (en) Treatment of benign prostatic hyperplasia
HUP0204467A3 (en) Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10
AU3735900A (en) Methods of treatment and prevention of restenosis
HK1056828A1 (en) Treatment of burns.
IL178303A0 (en) Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia